Table 4. Association of the MRSs with (A) subclinical atherosclerosis in the REGICOR cohort (N=534) and (B) CVD or CHD incidence in the Framingham Offspring Cohort.
A. Subclinical atherosclerosis | ||||||
---|---|---|---|---|---|---|
| ||||||
Subclinical atherosclerosis |
MRS | Model 1 | Model 2 | |||
Coeff | P-value | Coeff | P-value | |||
Pulse wave velocity | Left | Residuals | −1.3·10−2 | 1.92·10−4 | −1.08·10−2 | 1.26·10−2 |
Δage | −1.3·10−2 | 1.92·10−4 | −1.08·10−2 | 1.26·10−2 | ||
Right | Residuals | −8.47·10−3 | 7.64·10−3 | −3.55·10−3 | 3.79·10−1 | |
Δage | −8.47·10−3 | 7.63·10−3 | −3.55·10−3 | 3.79·10−1 | ||
Distensibility coefficient | Left | Residuals | 2.59·10−2 | 1.59·10−4 | 2.36·10−2 | 5.75·10−3 |
Δage | 2.59·10−2 | 1.59·10−4 | 2.36·10−2 | 5.74·10−3 | ||
Right | Residuals | 1.83·10−2 | 3.7·10−3 | 9.42·10−3 | 2.4·10−1 | |
Δage | 1.83·10−2 | 3.7·10−3 | 9.42·10−3 | 2.4·10−1 |
B. CVD or CHD incidence | |||||
---|---|---|---|---|---|
| |||||
Incidence | MRS | Model 1 | Model 2 | ||
| |||||
Hazard ratio and 95% CI |
P-value | Hazard ratio and 95% CI |
P-value | ||
CVD (n=222) | Residuals | 1.32 (1.16;1.51) | 2.20·10−5 | 1.28 (1.09;1.51) | 3.09·10−3 |
Δage | 1.33 (1.17;1.51) | 1.10·10−5 | 1.30 (1.10;1.53) | 1.74·10−3 | |
CHD (n=94) | Residuals | 1.08 (0.88;1.32) | 4.84·10−1 | 0.97 (0.75;1.26) | 8.30·10−1 |
Δage | 1.09 (0.89;1.34) | 4.17·10−1 | 0.99 (0.76;1.28) | 9.34·10−1 |
Coeff, Linear Regression Coefficients; MRS, Methylation Risk Score; CVD, Cardiovascular Disease; CHD, Coronary-Heart Disease; CI, Confidence Intervals.